The DG of NAFDAC says the agency has approved the use of Oxford/AstraZeneca COVID-19.
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the Oxford/AstraZeneca COVID-19 vaccine for use in Nigeria.
This information was made public by Bashir Ahmad, the Personal Assistant on New Media to President Muhammadu Buhari, today the 18th of February 2021.
According to his statement, the Director-General of the Agency, Dr. Mojisola Adeyeye made this decision based on the recommendation of the agency after rigorous scientific considerations conducted by NAFDAC
